Hospital Universitario Puerta del Mar -ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2018

  1. Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: The ANICE-PaC study

    BMC Cancer, Vol. 18, Núm. 1